Jakavi

Jakavi Description

ruxolitinib

Manufacturer:

Novartis

Distributor:

DKSH
Full Prescribing Info
Description
Jakavi 5 mg tablets: Each tablet contains 5 mg ruxolitinib (as phosphate).
Excipient with known effect: Each tablet contains 71.45 mg lactose monohydrate.
Jakavi 15 mg tablets: Each tablet contains 15 mg ruxolitinib (as phosphate).
Excipient with known effect: Each tablet contains 214.35 mg lactose monohydrate.
Jakavi 20 mg tablets: Each tablet contains 20 mg ruxolitinib (as phosphate).
Excipient with known effect: Each tablet contains 285.80 mg lactose monohydrate.
Excipients/Inactive Ingredients: Microcrystalline cellulose, Magnesium stearate, Colloidal anhydrous silica, Sodium starch glycolate, Povidone, Hydroxypropylcellulose, Lactose monohydrate.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in